The gene editing company will focus on “in vivo” medicines, while seeking to license out or find a development partner for ...
Find Latest News, Videos and Pictures about CRISPR. Explore latest updates, news, information from NewsBytes. All about CRISPR.
Early data from Wave Life Sciences suggests how editing RNA may yield viable medicines. Large and small drugmakers say such ...
EDT Cathie Wood’s ARK Investment bought 47.8K shares of Crispr Therapeutics (CRSP) today Published first on TheFly – the ...
On The Readout LOUD, John Maraganore discusses his new startup, and STAT's Megan Molteni tells the latest about "CRISPR baby" ...
Hosted on MSN2d
Wall Street Analysts See a 67.54% Upside in CRISPR Therapeutics (CRSP): Can the Stock Really Move This High?CRISPR Therapeutics AG (CRSP) closed the last trading session at $48.92, gaining 1.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by ...
Award from Highly Competitive Initiative Will Enable Ancilia to Advance Its Lead Program through IND Filing for Its First Clinical ...
An editorial by Fyodor Urnov lays out the urgent case for major reform in the regulatory appraisal of clinical therapies involving CRISPR gene therapies.
7don MSN
In a potential advance for melanoma patients, researchers at ChristianaCare's Gene Editing Institute have used CRISPR gene ...
Editas Medicine (EDIT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Jack Allen ...
An invited Guest Editorial entitled “Give Cas a Chance,” by Fyodor Urnov, PhD, Director of Technology & Translation at the ...
CRISPR technology allows for precise DNA modifications, holding promise for treating genetic disorders and revolutionizing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback